The Health Insurance Portability and Accountability Act of 1996 was enacted by the United States Congress and signed by President Bill Clinton in 1996. It has been known as the KennedyKassebaum Act or Kassebaum-Kennedy Act after two of its leading sponsors. Title I of HIPAA protects health insurance coverage for workers and their families when they change or lose their jobs. Title II of HIPAA, known as the Administrative Simplification (AS) provisions, requires the establishment of national standards for electronic health care transactions and national identifiers for providers, health insurance plans, and employers.
HIPAA Compliance: Protecting your patients health information is more difficult and more important than ever. HIPAA rules have been adopted which pertain to all Protected Health Information (PHI) including paper and electronic, as well as dealing specifically with Electronic Protected Health Information (EPHI).
Envoy Data has gone to great lengths to design-in solutions that are HIPAA compliant, and ready to easily be added to your existing infrastructure and make your company compliant with these government mandates.
The HITECH Act (Health Information Technology for Economic and Clinical Health Act) requires entities covered by the HIPAA to report data breaches, which affect 500 or more persons, to the United States Department of Health and Human Services (U.S.HHS), to the news media, and to the people affected by the data breaches.
- Health Care Weekly Preview from ML Strategies – Week of July 17, 2017Our colleagues at ML Strategies have provided a Health Care Weekly Preview. This week’s preview describes the Better Care Reconciliation Act (BCRA), the User Fee Acts (UFAs), the National Defense Authorization Act (NDAA), and the health care Minibus. Stay tuned for additional updates and analysis from ML Strategies. The post Health Care Weekly Preview from ML Strategies – Week […]
- Six Questions and Answers About CMS’ Recommended Changes to 340B Medicare ReimbursementIn March, I posted about the Uncertain Future of the 340B Drug Discount Program. When opining about What Could Happen Next I speculated about possible changes to government reimbursement for 340B drugs “so that government safety net programs share in 340B savings.” I reasoned that CMS already knew that “Medicare pays more for 340B drugs... […]
- FDA Delays Enforcement of Prescription Drug Product Identifier and Related RequirementsFacing pressure from stakeholders and technological realities, the U.S. Food and Drug Administration has again delayed its enforcement of parts of the Drug Supply Chain Security Act (DSCSA). As we discussed in a prior post, the DSCSA requires enhanced security and accountability for prescription drugs throughout the U.S. pharmaceutical supply chain, with phased-in obligations for the various trading partners over 10 years, beginning... […]
- Health Care Weekly Preview from ML Strategies – Week of July 10, 2017Our colleagues at ML Strategies have provided a Health Care Weekly Preview. This week’s preview describes the ongoing wrangling in the Senate over health care reform as well as highlighting the upcoming need to address FDA User Fees and the health care minibus. Stay tuned for additional updates and analysis from ML Strategies. The post Health Care Weekly Preview […]
- FDA Stays in the Spotlight with Drug Pricing Moves, but Could Be Facing Risk as UFA Bill Loses AttentionIt appears that – at least for now – the U.S. Food and Drug Administration (FDA) is serving as the public face of the executive branch’s efforts to tackle the increasingly contentious debate about prescription drug prices. As we previously reported, following a May 25, 2017 budget hearing, FDA Commissioner Scott Gottlieb has made increased competition... […]
- Drug Makers Not Off the Hook as States Continue to Take Action to Control Drug PricesEarlier this month, two states – Maryland and Nevada – passed legislation aimed at controlling drug prices. The two laws are being touted by proponents as decisive action against pharmaceutical manufacturers. Opponents note that the laws have limitations and are really more of an annoyance for drug makers and will not do anything to help... […]
- Massachusetts House & Senate Tackle MarijuanaThe Massachusetts legislature has targeted July 1, 2017 as the date by which it will have legislation on Governor Charlie Baker’s desk regarding the commercial cultivation, processing, and sale of non-medicinal cannabis products for adult use. On June 23rd, the House and Senate each appointed members to a 6-member conference committee that is tasked with resolving the... […]
- What’s CHIP Got to Do With It?Children in United States receive their health insurance from multiple sources: the Children’s Health Insurance Program (CHIP), Medicaid, employer-sponsored insurance, or a qualified health plan on the Marketplace. This creates a fragmented system of coverage for children and families, particularly for low- and moderate-income families, who often have children and parents enrolled in across separate coverage... […]
- Capitol Hill Update: Affordable Care Act Repeal on the Ropes?UPDATE: Shortly after this post went live, Senate Majority Leader Mitch McConnell announced that he would be delaying the vote on the Better Care Reconciliation Act until after the Fourth of July recess. Stay tuned for further updates and analysis from the team at ML Strategies! The Senate bill to repeal the Affordable Care Act is... […]
- CMS Releases the Final Medicare Part D DIR Reporting Requirements for 2016On Friday, June 23, 2017, CMS released the Final Medicare Part D DIR Reporting Requirements for 2016. Part D sponsors may begin submitting their DIR information on June 30, 2017 and must finish their submissions by the end of July 31, 2017. As explained in our earlier post, CMS publishes Part D DIR Reporting requirements... […]